Who are the leading companies in the sclerotherapy market?

Key players include AccuVein, Angiodynamics, B. Braun, Biolitec, BTG International, Kreussler & Co., Cook Medical, Endo-Med Technologies, Merz Pharma, Sanofi, Terumo, and Vascular Solutions.

What trends are shaping the sclerotherapy market through 2030?

Major trends include preference for minimally invasive procedures, advancements in sclerosant formulations, expanding global access, and increased focus on outpatient treatments.

12 Leading Sclerotherapy Companies Shaping Market Innovation Through 2030

Explore the most influential players in the global sclerotherapy market. This analysis spotlights 12 leading sclerotherapy companies, providing actionable insight into their expertise, competitive edge, and impact. For comprehensive market intelligence, growth forecasts, and in-depth competitive analysis, access the full Sclerotherapy Market by Type, Product, Application, End User - Global Forecast to 2030 report.

Sclerotherapy Market Trends and Leading Players

The sclerotherapy market stands at the intersection of technological advancement, increased global demand, and a pronounced shift toward minimally invasive treatments for venous disorders. The following market leaders are driving clinical innovation, expanding global access, and responding to evolving end-user requirements highlighted in the latest sector research.

Company Spotlights: 12 Leading Sclerotherapy Companies

1. AccuVein, Inc.

AccuVein, Inc. is recognized for its cutting-edge vascular imaging devices, providing real-time vein visualization that enhances the precision and safety of sclerotherapy procedures. Their technology-driven approach streamlines clinical workflows and supports superior patient outcomes—key differentiators in modern vein care.

2. Angiodynamics Inc.

Angiodynamics Inc. stands out with its broad portfolio of minimally invasive solutions for vascular intervention. The company leverages clinical research and technology advancement to offer custom sclerotherapy solutions, catering to both ambulatory surgery centers and hospital networks.

3. B. Braun Melsungen AG

B. Braun Melsungen AG brings deep expertise in medical devices and pharmaceutical products, with a robust presence in the global sclerotherapy market. Their focus on safety, reliability, and clinician education ensures hospitals and outpatient centers benefit from state-of-the-art sclerotherapy systems.

4. Biolitec AG

Biolitec AG is renowned for its laser and photodynamic therapies, including advanced technologies for venous treatments. Their continuous R&D investments support integrated, minimally invasive platforms that improve procedural efficiency in sclerotherapy.

5. BTG International Ltd.

BTG International Ltd. delivers innovative interventional medicine solutions, with dedicated sclerotherapy and embolotherapy product lines. The company's global footprint and commitment to regulatory excellence make it a trusted supplier across diverse healthcare markets.

6. Chemische Fabrik Kreussler & Co. GmbH

Chemische Fabrik Kreussler & Co. GmbH has built a legacy in pharmaceutical innovation, particularly with sclerosant agents used in foam and liquid sclerotherapy. Their emphasis on patient safety and product efficacy upholds leading standards for outpatient treatments worldwide.

7. Cook Medical Inc.

As a pioneer in minimally invasive medical technology, Cook Medical Inc. offers an extensive suite of sclerotherapy devices designed for accuracy and adaptability. Their global logistics and diverse supply chain mitigate regional access challenges for healthcare providers.

8. Endo-Med Technologies Pvt. Ltd.

Headquartered in Asia-Pacific, Endo-Med Technologies Pvt. Ltd. specializes in designing and manufacturing innovative sclerotherapy equipment tailored to emerging market needs. Their focus on affordability without compromising performance promotes broader market adoption.

9. Merz Pharma GmbH & Co. KGaA

Merz Pharma’s leadership in aesthetics and dermatology extends to the sclerotherapy sector, where their sclerosant products and clinical support services are widely used in cosmetic vein procedures. The company integrates clinician training as a core element of its global strategy.

10. Sanofi S.A.

Sanofi S.A., a global healthcare giant, offers a range of pharmaceuticals, including agents used in sclerotherapy. Their worldwide reach, continuous clinical research, and strong regulatory record position them as a trusted choice for hospitals and specialty clinics.

11. Terumo Corporation

Terumo Corporation leverages decades of experience in medical device innovation, focusing on user-friendly, safe, and effective sclerotherapy instruments. Their robust R&D pipeline emphasizes modular systems that adapt to the diverse requirements of ambulatory care centers.

12. Vascular Solutions, Inc.

Vascular Solutions, Inc. specializes in developing targeted solutions for vascular intervention, including specialized devices for sclerotherapy. They stand out for their customer-centric product design and ability to quickly respond to changing clinical trends in vein care.

Access the Complete Sclerotherapy Market Intelligence

To benchmark strategy, discover in-depth trends, and unlock actionable competitive analysis on the leading sclerotherapy companies, access the Sclerotherapy Market by Type, Product, Application, End User - Global Forecast to 2030 report.

Discover the 12 leading sclerotherapy companies shaping market innovation, trends, and clinical excellence. Get comprehensive insights and strategic analysis for 2025–2030.